MatthewFuryMD

Clinical Trials

• Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Nov 01

  Completed

  Phase 1

• Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 2

• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Start of enrollment: 2008 Jul 01

  Completed

  Phase 2

• Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2008 Aug 01

  Completed

  Phase 1

• Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer Start of enrollment: 2009 Mar 01

  Completed

  Phase 1

• RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer Start of enrollment: 2009 Jul 01

  Completed

  Phase 1

• Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma Start of enrollment: 2009 Aug 01

  Completed

  Phase 2

• Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) Start of enrollment: 2009 Nov 01

  Completed

  Phase 1, Phase 2

• Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma Start of enrollment: 2010 Dec 28

  Completed

  Not Applicable

• BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors Start of enrollment: 2011 Feb 15

  Completed

  Phase 1

• A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2012 Nov 12

  Terminated

  Phase 1, Phase 2

• Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) Start of enrollment: 2012 Nov 01

  Completed

  Phase 1

• Phase 1b Trial of BGJ398/BYL719 in Solid Tumors Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors Start of enrollment: 2014 May 14

  Completed

  Phase 1

• Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies Start of enrollment: 2014 Aug 07

  Terminated

  Phase 1

• Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy Start of enrollment: 2014 Jul 28

  Terminated

  Phase 1

• Join now to see all